Trial
NCT03315052
Budesonide for Immunosuppression After Liver Transplantation to Reduce Side Effects
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Montefiore Medical Center
Collaborators
—
Condition
Acute Cellular Graft Rejection
Intervention
Budesonide
Why stopped
Delay in IRB approval
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-09-23